Latest Working Capital News

Redcastle Resources has cleared key regulatory hurdles at Queen Alexandra and Redcastle Reef, setting the stage for mining operations and potential first gold revenues in 2026 under a capital-light joint venture with BML Ventures.

Matsa Resources has kicked off a major diamond drilling campaign at Fortitude North targeting up to 1.85 million ounces of gold while reporting robust $28.7 million gold sales and $6.1 million EBITDA from the Devon Pit Gold Mine.

Rumble Resources has completed a major diamond drilling campaign at Western Queen, delivering multiple high-grade gold and tungsten intersections that underpin an advancing feasibility study and mine development plans.

Chariot Resources advances its Nigerian lithium acquisition with six licences transferred and spodumene confirmed in samples, while raising A$2.15 million and securing a A$3.5 million loan refinancing.

Cobre Limited has secured majority control of the Sierra Atacama Copper Project in Chile through a $60 million capital raise, marking its transition from explorer to producer. The company plans extensive drilling and operational upgrades to boost production and resource confidence.

Blue Star Helium has completed Stage 1 of its Galactica development, tying six wells into the Pinon Canyon facility and starting spot-priced helium sales. The company raised A$10 million to fund further project expansion and working capital.

Freehill Mining’s aggregates business surged with a 59% jump in quarterly sales, while new copper project options promise to shift the company’s growth trajectory.

ReNerve Limited reports a 79% jump in quarterly sales, secures key Asia-Pacific approvals, and progresses its nerve repair pipeline with the NervAlign Nerve Guide Matrix entering Stage 3 development.

C29 Metals is making a bold entry into Namibia’s Tier 1 Otavi Copper Belt through an 80% acquisition of a large copper-gold portfolio, backed by a $4.7 million capital raise and promising high-grade drill results.

Sunshine Metals is set to transform its gold production profile with the $18 million acquisition of the Mt Moss processing facility and a $22 million capital raise to fund expansion and exploration.

Zimi Limited posted 14% revenue growth and landed its biggest project order to date with Homecorp, while slashing operating costs and launching an AI sales agent.

Rhythm Biosciences marked a pivotal shift from development to commercial diagnostics in Q3 FY26, recording its first ColoSTAT® clinical sale and initiating NHS England evaluation while expanding geneType™ partnerships across Asia and Australia.